Management of Hypertension in a 67-Year-Old Patient on Lercanidipine
For a 67-year-old patient with hypertension on lercanidipine 20 mg once daily with current BP readings of 139/79 mmHg in the morning and 147/81 mmHg in the evening, the next step should be to add a thiazide/thiazide-like diuretic to the current regimen.
Current Status Assessment
The patient is currently on:
- Lercanidipine 20 mg once daily (maximum dose of this dihydropyridine calcium channel blocker)
- Morning BP: 139/79 mmHg (borderline controlled)
- Evening BP: 147/81 mmHg (above target)
Blood Pressure Target Analysis
According to the 2020 International Society of Hypertension (ISH) guidelines 1:
- Target BP should be <130/80 mmHg for most patients
- For elderly patients, targets may be individualized based on frailty
- The evening BP reading of 147/81 mmHg exceeds the hypertension threshold of ≥140/90 mmHg
- The morning reading is borderline but still above optimal targets
Treatment Algorithm
The patient's current status indicates:
- Maximum dose of lercanidipine (20 mg) has been reached
- BP is not adequately controlled, particularly in the evening
- Patient is 67 years old, which places them in a higher risk category
Following the ISH 2020 drug therapy steps for non-black patients 1:
- ✓ Started with a calcium channel blocker (lercanidipine)
- ✓ Increased to full dose (20 mg)
- → Next step: Add a thiazide/thiazide-like diuretic
Evidence for Current Treatment
Lercanidipine is an effective dihydropyridine calcium channel blocker:
- It has a long receptor half-life and slow onset of action, which helps avoid reflex tachycardia 2
- At 20 mg/day, it has shown efficacy comparable to amlodipine 10 mg/day 3
- It is effective in elderly patients (aged 60-85 years) with mild to moderate hypertension 4
Rationale for Adding a Thiazide Diuretic
- The patient has reached the maximum dose of lercanidipine (20 mg)
- Evening BP readings remain elevated (147/81 mmHg)
- The ISH 2020 guidelines specifically recommend adding a thiazide/thiazide-like diuretic as the next step after maximizing calcium channel blocker dosage 1
- Combination therapy with different mechanisms of action provides synergistic effects
Monitoring Recommendations
After adding the thiazide/thiazide-like diuretic:
- Reassess BP control within 4 weeks
- Target should be to achieve BP <130/80 mmHg throughout the day
- Monitor for electrolyte abnormalities, particularly potassium and sodium levels
- Assess for potential side effects of the combination therapy
Common Pitfalls to Avoid
- Inadequate dose titration: The patient is already on maximum dose of lercanidipine, so further dose increases are not an option
- Switching medications unnecessarily: Lercanidipine appears well-tolerated as no adverse effects were mentioned, so adding a complementary agent is preferable to switching
- Ignoring diurnal BP variations: The evening BP elevation is significant and should not be ignored
- Delaying treatment intensification: At age 67, prompt BP control is important to reduce cardiovascular risk
If BP remains uncontrolled after adding a thiazide diuretic, the next step would be to consider adding spironolactone or another agent such as an ACE inhibitor or ARB, according to the ISH 2020 treatment algorithm 1.